[Menoflavon and lipid profile in menopausal women]

The purpose of the study was to assess the effect of Menoflavon on plasma lipoprotein levels in menopausal women. Twenty-eight female patients were examined and treated. After a 3-month treatment, the authors established a reduction of the total plasma cholesterol levels by 7.15%. This reduction was more considerable (by 11.45%) in the females presenting with higher risk values (> 6.20 mmol/L). After a 6-month treatment, however, the subsequent cholesterol reduction was insignificant and the plasma levels were stabilized. Menoflavon therapy diminished plasma LDL-cholesterol levels by 8.71% after a 3-months long course and by 9.5% after a 5-months long one in comparison with the initial levels. Menoflavon did not exert any effect on the plasma levels of HDL-cholesterol and triglycerides as well.